Tuesday, February 24, 2015 9:06:19 AM
Spark Therapeutics Receives New Coverage from Analysts at Cowen and Company (ONCE)
Posted by Stephan Byrd on Feb 24th, 2015 // No Comments
Share on StockTwits
Spark Therapeutics logoInvestment analysts at Cowen and Company initiated coverage on shares of Spark Therapeutics (NASDAQ:ONCE) in a note issued to investors on Tuesday, TheFlyOnTheWall.com reports. The firm set an “outperform” rating on the stock.
ONCE has been the subject of a number of other recent research reports. Analysts at Credit Suisse initiated coverage on shares of Spark Therapeutics in a research note on Tuesday. They set an “outperform” rating on the stock. Analysts at JPMorgan Chase & Co. initiated coverage on shares of Spark Therapeutics in a research note on Tuesday. They set an “overweight” rating on the stock. Analysts at Rodman & Renshaw initiated coverage on shares of Spark Therapeutics in a research note on Sunday. They set a “buy” rating and a $71.00 price target on the stock. Finally, analysts at Roth Capital initiated coverage on shares of Spark Therapeutics in a research note on Thursday, February 19th. They set a “buy” rating and a $72.00 price target on the stock. Five equities research analysts have rated the stock with a buy rating, The stock has a consensus rating of “Buy” and an average price target of $71.50.
Spark Therapeutics (NASDAQ:ONCE) opened at 56.68 on Tuesday. Spark Therapeutics has a 52 week low of $40.50 and a 52 week high of $57.24. The stock’s 50-day moving average is $46.85 and its 200-day moving average is $46.85.
Spark Therapeutics, Inc is engaged in the field of gene therapy. The Company develops one-time, life-altering treatments for patients suffering from debilitating genetic diseases. The Company is focused on treating rare diseases where no, or only palliative therapies exist. The Company addresses a range of debilitating genetic diseases including inherited retinal dystrophies, hematologic disorders and neurodegenerative diseases.
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM